VIVEK SUBBIAH to Boron Compounds
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Boron Compounds.
Connection Strength
0.377
-
A phase i study of ixazomib and erlotinib in patients with advanced solid tumors. Invest New Drugs. 2022 02; 40(1):99-105.
Score: 0.199
-
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. Sci Rep. 2020 02 20; 10(1):3080.
Score: 0.179